Recipharm has successfully completed a serialization project for China for a top ten pharma company. The new serialization regulation introduced by the Chinese regulatory authority has set strict importation deadlines with no flexibility on full compliance.
 
Recipharm developed an adaptable solution using a methodical approach to ensure compliance, and 57 serialized batches have been supplied since February 2014. Recipharm worked closely with the pharmaceutical customer to exchange ideas and information. New technology was also introduced and applied to ensure each individual box has its own 1D barcode and unique serial number.  
 
Stéphane Guisado, general manager at Recipharm Fontaine said, “We are very pleased with the success of this China focused serialization project carried out for the pharma partner concerned. Traditionally, full compliance with China’s regulations, especially in the field of serialization, has proved to be a major challenge for the pharma sector. There is no room for compromise when it comes to meeting regulatory deadlines. Moreover, the time-lines set by laws have to be met in full and on time and are often imposed with relatively short notice regarding implementation lead time. Recipharm has now developed the skills and knowledge to provide a platform for delivering a serialization solution for all markets.”